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Exposure to air pollution increases the risk of cardiovascular 
morbidity and mortality, especially in susceptible populations. 
Despite increased risk, adverse responses are often delayed and 
require additional stress tests to reveal latent effects of expo-
sure. The goal of this study was to use an episode of “transient 
hypoxia” as an extrinsic stressor to uncover latent susceptibility to 
environmental pollutants in a rodent model of hypertension. We 
hypothesized that exposure to acrolein, an unsaturated aldehyde 
and mucosal irritant found in cigarette smoke, diesel exhaust, and 
power plant emissions, would increase cardiopulmonary sensitiv-
ity to hypoxia, particularly in hypertensive rats. Spontaneously 
hypertensive and Wistar Kyoto (normotensive) rats, implanted 
with radiotelemeters, were exposed once for 3 h to 3 ppm acrolein 
gas or filtered air in whole-body plethysmograph chambers and 
challenged with a 10% oxygen atmosphere (10 min) 24 h later. 
Acrolein exposure increased heart rate, blood pressure, breath-
ing frequency, and minute volume in hypertensive rats and also 
increased the heart rate variability parameter LF, suggesting a 
potential role for increased sympathetic tone. Normotensive rats 
only had increased blood pressure during acrolein exposure. The 
hypoxia stress test after acrolein exposure revealed increased dias-
tolic blood pressure only in hypertensive rats and increased min-
ute volume and expiratory time only in normotensive rats. These 
results suggest that hypertension confers exaggerated sensitivity 
to air pollution and that the hypoxia stress test is a novel tool to 
reveal the potential latent effects of air pollution exposure.
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Exposure to air pollution increases cardiovascular morbid-
ity and mortality, especially in individuals with pre-existing 
cardiovascular diseases (Brook et al., 2010). Epidemiological 
studies indicate that these effects are not immediate, usually 
manifesting some time after exposure. For example, Peters 
et al. (2004) showed that humans exposed to traffic were more 
susceptible to myocardial infarction up to 24 h after exposure. 
In addition, patients with implanted cardioverter defibrillators 
had increased incidence of life-threatening arrhythmias up to 
2 days after air pollution exposure (Peters et al., 2000). These 
findings suggest that exposure to air pollution alters cardiovas-
cular physiology and increases conditional susceptibility to 
triggers of thrombosis and arrhythmia. Moreover, the fact that 
these effects happen at lower exposure concentrations than 
those shown to elicit effects in animal studies indicates that 
the responses are more complicated than the standard mono-
tonic dose-response relationship of traditional toxicology. The 
reduced capacity to compensate to daily stressors may account 
for the “lagged” responses associated with air pollution expo-
sure. The study of the factors that determine the capacity to 
compensate fully presents a potentially informative approach 
when seeking to uncover and explain the latent effects of air 
pollution exposure.
A stress test is a common way to reveal enhanced sensitivity 
or the potential for adverse responses because increased 
cardiovascular effort causes reduced oxygen availability to 
tissues and may provoke autonomic imbalance (Goldberger 
et  al., 2006). Numerous studies have shown that stress tests 
trigger many adverse cardiovascular effects including increased 
cardiac arrhythmias and deleterious changes in heart rate (HR), 
heart rate variability (HRV), an indirect indicator of cardiac 
autonomic tone, and electrocardiogram (ECG) parameters 
(Watanabe et al., 2001). Recently, exercise stress was used to 
demonstrate that exposure to diesel exhaust during exercise 
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in men with coronary artery disease caused myocardial 
ischemia (Mills et  al., 2007). Analogous effects, including 
increases in cardiac arrhythmia and myocardial ischemia, 
were demonstrated in rats infused with the sympathomimetic 
dobutamine 1  day after exposure to diesel exhaust (Hazari 
et  al., 2012). In addition, rats exposed to particulate matter 
or acrolein had exaggerated sensitivity to aconitine, an agent 
that causes myocardial calcium loading (Hazari et al., 2009). 
These results are consistent with epidemiological evidence for 
a time lag in responses and highlight the value of stress tests in 
unmasking latent responses.
We have previously demonstrated that exposure to both par-
ticulate and gaseous air pollutants, including acrolein, causes 
exaggerated cardiovascular effects in rat models of hyperten-
sion and heart failure (Carll et al., 2012; Farraj et al., 2011; 
Hazari et al., 2009; Lamb et al., 2012). Whereas the mecha-
nisms responsible for these effects are unclear, recent work 
by Wang et al. (2012) demonstrated that cardiac arrhythmias 
in particulate-exposed heart failure mice were in part due to 
altered sensitivity of the carotid body, a key organ involved in 
oxygen sensing and initiating reflex cardiopulmonary changes 
to maintain homeostasis. Furthermore, exposures to the air 
pollutants, tobacco smoke (Adgent, 2006), sulfur dioxide, and 
nitrogen dioxide (Hoppenbrouwers et  al., 1981), have been 
linked to abnormal cardiopulmonary sensitivity responses to 
hypoxia. These findings suggest that the response to hypoxia 
may be useful in unmasking the latent effects of air pollution. 
The purpose of this study was to (1) examine the utility of 
a novel hypoxia stress test in revealing the potential latent 
effects of air pollution and (2) test the hypothesis that acrolein 
exposure will modify the response to hypoxia in hypertensive 
rats, but not in normal rats, given that hypertensive individu-
als have exaggerated sensitivity to low atmospheric oxygen 
(Yu et  al., 1999). HR, blood pressure (BP), ECG, and HRV 
were measured during acrolein exposure and 1 day later during 
hypoxia challenge.
MATEriALS AND METhoDS
Animals. Twelve-week-old male spontaneously hypertensive (SH) (n = 6) 
and Wistar Kyoto (WKY) normotensive (n = 6) rats (Charles River, Raleigh, 
NC) were housed in plastic cages (one per cage), maintained on a 12-h light/
dark cycle at approximately 22°C and 50% relative humidity in our Association 
for Assessment and Accreditation of Laboratory Animal Care-approved facil-
ity, and held for a minimum of 1 week before exposure. Food (Prolab RMH 
3000; PMI Nutrition International, St Louis, MO) and water were provided ad 
libitum, and all rats were randomized by weight. After all experiments were 
performed, rats were deeply anesthetized with an ip injection of Euthasol 
(200 mg/kg Na pentobarbital and 25 mg/kg phenytoin; Virbac Animal Health, 
Fort Worth, TX) and euthanized by exsanguination. The Institutional Animal 
Care and Use Committee of the U.S. Environmental Protection Agency (U.S. 
EPA) approved all protocols.
Telemeter implantation. Animals were implanted with radiotelemetry 
transmitters to monitor HR, BP, and heart rhythms and electrocardiographic 
intervals (Model TL11M2-C50-PXT; Data Science International, Inc., St 
Paul, MN). Charles River Laboratories performed all telemetry implantation 
surgeries in accordance with methods specified by the vendor (Charles River 
Laboratories, 2005). Animals were shipped to the U.S. EPA 10  days after 
implantation surgeries, and animals were allowed to recover for 1 week at the 
U.S. EPA before exposures began.
A separate cohort of SH (n = 5) and WKY (n = 5) rats were implanted with 
femoral artery catheters in accordance with methods specified by the vendor 
(Charles River Laboratories, 2005). Animals were shipped to the U.S. EPA 
within 1 week of surgery. The catheters were flushed with saline, locked with 
heparin, and plugged immediately upon arrival and every 2 days thereafter until 
exposure began.
Acrolein exposure and hypoxia stress test. A paired design was utilized 
to control for baseline differences in HR, BP, and ECG rhythms between rats. 
SH and WKY rats were first exposed to air control for 3 h and then underwent 
a hypoxia stress test 24 h later. The hypoxia stress test was performed 24 h after 
acrolein exposure to uncover latent responses consistent with the delay between 
exposure and adverse health effects observed in some epidemiological studies 
(Peters et al., 2000, 2004). Exposure to subatmospheric oxygen has been used 
as a stress test in humans with hypertension to demonstrate exaggerated cardi-
orespiratory responses to hypoxia (Ledderhos et al., 2002). After 5 days, these 
same rats were exposed to 3 ppm acrolein for 3 h and then underwent a second 
hypoxia stress test 24 h later (please refer to Fig. 1A). We assumed that a period 
of 5 days between the initial hypoxia stress test and the subsequent exposures 
would allow residual effects, if any, of the initial hypoxia stress test to lapse. 
This was confirmed by the absence of any differences in air-exposed rats at 
baseline relative to the previous air and hypoxia exposures.
All exposures (air and acrolein) and the hypoxia stress test took place in 
whole-body plethysmography (WBP) chambers (Model PLY3213, Buxco 
Electronics, Inc., Wilmington, NC), which continuously and noninvasively 
monitor ventilatory parameters in conscious animals. All rats were acclimated 
to the chambers for 1 h two days prior to both air and acrolein exposure. On 
exposure days, rats were allowed to acclimate to exposure chambers for 30 min, 
and then baseline data were recorded for the next 30 min. For air exposure, rats 
were exposed to filtered air in WBP chambers for 3 h. HR, systolic and dias-
tolic BP, ECG waveforms, and ventilatory data were collected during the entire 
exposure period. After exposure, animals were returned to their home cages. 
Twenty-four hours after air exposure, animals underwent a hypoxia stress test. 
Animals were placed in WBP chambers and allowed to acclimate for 30 min. 
A 30-min baseline was then recorded. After baseline measurements, animals 
were kept at 20% oxygen concentration (ambient O
2
 concentration) for 5 min 
before the hypoxia stress test. To reduce the PO
2
 in the chamber, 100% nitrogen 
(N
2
) gas was delivered to a glass mixing chamber where the gas was mixed 




) of 10% at a flow 
rate of 2 L/min. Oxygen levels were monitored continuously with an O
2
 sen-
sor attached directly to the chamber, and an FIO
2
 of 10% was maintained for 
10 min. Nitrogen was then turned off, and the FIO
2
 oxygen saturation rose to 
20% (Fig. 1B). Rats were then kept in the chambers for an additional 15 min. 
HR, systolic and diastolic BP, ECG waveforms, and ventilatory data were col-
lected continuously during the stress test.
Five days after air exposure and the hypoxia stress test when all latent 
preconditioning was absent, these same rats were exposed to 3 ppm acrolein 
for 3 h in the same WBP chambers. The concentration of acrolein (3 ppm) is 
higher than ambient levels, but it may represent concentrations in high com-
bustion areas (Hazari et  al., 2008). In addition, cigarette smoke contains up 
to 90 ppm acrolein (Esterbauer et al., 1991), and acrolein levels in sidestream 
tobacco smoke are as high as 10 ppm (Esterbauer et al., 1991). Acrolein gas 
was metered from a 1000 ppm cylinder into a glass mixing chamber where 
the gas was mixed with dry filtered dilution air to achieve a final concentra-
tion of 3 ppm of acrolein with a total flow of 6 L/min. The actual chamber 
concentration was measured using an HP5890 gas chromatograph (GMI Inc., 
Ramsey, MN) equipped with manual injection, a flame ionization detector, and 
a DB-VRX capillary column. The plethysmograph pressure was monitored 
using Biosystems XA software (Buxco Electronics, Inc.). Using respiratory-
induced fluctuations in ambient pressure, respiratory parameters including 
tidal volume, breathing frequency, inspiratory time, and expiratory time were 
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Fig. 1.  A novel hypoxia stress test may reveal latent sensitivity to a gaseous pollutant. Panel (A) describes the experimental design for the study. Rats were 
exposed to air for 3 h on day 1 and underwent a hypoxia stress test 24 h after air exposure. These same rats were given a 5-day washout period and then exposed to 
3 ppm acrolein for 3 h followed by a hypoxia stress test 24 h after acrolein exposure. The hypoxia stress test consists of a 30-min baseline, the descend period (time 
it takes for FIO
2
 to decrease from 20 to 10%), a 10-min hypoxia period (10% FIO
2
, an ascend period—time it takes for FIO
2
 to increase from 10 to 20%), and a 
15-min period after the return to normal FIO
2
 (20%). Panel (B) represents the hypoxia stress test experimental setup. The rat is placed in a Buxco plethysmograph 
that sits over a radiotelemetry receiver. Ventilatory, ECG, HR, and BP data are captured during the entire stress test. For hypoxia, nitrogen is metered into the 
plethysmograph, and an oxygen sensor attached to the plethysmograph records FIO
2
 in real time.
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calculated and recorded on a breath-by-breath basis and averaged over 10-s 
intervals. HR, systolic and diastolic BP, ECG waveforms, and ventilatory data 
were collected during the exposure, and animals were returned to their home 
cages after exposure. Rats underwent a hypoxia stress test 24 h later as previ-
ously described. Because the data collected were repeated measures, the data 
during acrolein exposure and the subsequent hypoxia stress test are presented 
as % change from air exposure and the initial hypoxia stress test, respectively.
Validation of hypoxia stress test. The hypoxia stress test was validated 




) during hypoxia challenge in 
a separate cohort of rats. Rats implanted with femoral artery catheters were 
acclimated to WBP chambers (Model PLY3213, Buxco Electronics, Inc.) for 
1 h two days prior to hypoxia validation. On the day of validation, the exterior-
ized catheter was extended with a 1-ml PE50 catheter attached to a 23-gauge 
adapter and run through a premeasured hole in the wall of the plethysmograph 
to allow for blood draws outside of the sealed exposure chamber. Rats were 
acclimated to the exposure chambers for 30 min and then underwent a 250-
µl blood draw while conscious and unrestrained within the chamber. This 
served as the baseline blood sample. Nitrogen was metered into the chamber 
to reduce the FIO
2
 to 10%, and a second 250-µl blood sample was taken after 
the FIO
2
 stabilized at 10%. The addition of N
2
 was discontinued, and a final 
250-µl blood sample was taken 15 min after the oxygen content of the cham-
ber stabilized at an FIO
2
 of 20%. For each blood draw, the pin was removed 
from the tip of the catheter, and the heparin was allowed to exit the catheter. 
When only blood remained, a 23-gauge adapter attached to a 1-ml syringe was 
placed at the end of the catheter and used to draw a 250-µl sample. The blood 
sample was immediately read on an OPTI CCA-TS Blood Analyzer (OPTI 





, Na+, K+, Ca2+, total hemoglobin, oxygen saturation (SaO
2
), and 
hematocrit. The catheter was flushed with saline and locked with heparin after 
each blood draw.
WBP data acquisition and analysis. All exposures were performed in 
WBP chambers (Buxco Electronics, Sharon, CT). The plethysmography meth-
odology permitted continuous monitoring of breathing frequency, tidal volume, 
minute volume, inspiratory time, and expiratory time. Animals were acclimated 
to plethysmographs for 1 h each day two days prior to exposure before both air 
and acrolein exposure. Plethysmography chambers (model PLY3213; Buxco 
Electronics) were calibrated each day before every animal loading. A  bias 
flow regulator delivered fresh air (1.8 L/min) to each cylindrical chamber, pre-
venting CO
2
 buildup within the chamber. Unrestrained animals were placed 
in individual cylindrical plethysmograph boxes containing a built-in reference 
chamber for measuring respiration-induced pressure fluctuations. Data were 
channeled to computer software (BioSystem XA; Buxco Electronics) that 
calculated respiratory parameters. Data were collected continuously for each 
parameter, and automated breath-by-breath analyses were performed using a 
rejection algorithm to eliminate breaths that were outside a given range. On 
exposure day, animals were acclimated to the chambers for 30 min before any 
readings were taken. After acclimation, 30 min of baseline data were taken, 
and animals were exposed to either control air or 3 ppm acrolein for 3 h. After 
exposure, rats were removed and returned to home cages.
Radiotelemetry data acquisition. Radiotelemetry methodology (Data 
Sciences International, Inc.) enabled constant monitoring of ECG data in 
unrestrained, unanesthetized rats from implantation until euthanasia. Remote 
receivers (DataART3.01; Data Sciences International, Inc.) were positioned 
under the home cages and under the plethysmographs during exposure, 
which collected the ECG data and transferred them to the computer for stor-
age. In home cages, sixty-second segments of ECG waveforms were acquired 
and saved at 15-min intervals from surgical recovery through euthanasia not 
including the exposure period. Pre-exposure baseline data were collected from 
home cages and a 30-min baseline in exposure cages after a 30-min acclima-
tion period. During the 3-h exposure, sixty-second segments were acquired 
and saved at 5-min intervals. After exposure, rats were monitored in home 
cages until euthanasia, approximately 18 h after the end of the final hypoxia 
challenge. HR and BP were automatically obtained from the ECG and BP 
waveforms, respectively, with data acquisition software (DataART3.01; Data 
Sciences International, Inc.).
ECG, arrhythmia identification, and HRV analysis.  ECGAuto software 
(EMKA Technologies, Falls Church, VA) was used for automated analyses of 
ECG wave amplitudes and segment durations and areas, as well as for the vis-
ual identification and enumeration of cardiac arrhythmias. Several parameters 
were determined for each ECG waveform: PR interval; R amplitude and dura-
tion; QRS area; ST interval, amplitude, and area; and T-wave amplitude and 
area; QT interval; and heart rate–corrected QT interval. ECG parameters during 
exposure were analyzed in terms of baseline (30 min recordings while in the 
exposure chambers immediately before the beginning of exposure) and hours 
1–3 (constituting the entire exposure period between 8:00 a.m. and 11:00 a.m.).
Cardiac arrhythmic events were identified in part by using the Lambeth con-
ventions (Walker et al., 1988) as a guideline for the identification of arrhyth-
mias in rats. Arrhythmias were identified as atrial premature beats, ventricular 
premature beats, sinoatrial blocks, atrioventricular blocks, or ventricular tachy-
cardia. Arrhythmias were quantified, counted, and totaled over an 18-h period 
prior to exposure (this corresponded to the same times assessed after exposure), 
during the 4-h exposure period, or during the 18-h period beginning immedi-
ately after exposure. Total arrhythmia counts during exposure were quantified 
(total of forty-eight 2-min segments during 3-h exposure period) and expressed 
as counts per minute.
For the analysis of HRV, thorough visual inspection was conducted to 
identify and exclude arrhythmias, artifacts, and 1-min ECG waveforms lack-
ing distinguishable R waves for more than 30 s. The analysis of HRV gener-
ated HR and time-domain measures, including mean time between adjacent 
QRS complex peaks (the RR interval), a standard deviation of the RR inter-
val (SDNN), SDNN normalized for the effects of HR (SDNN/[RR interval 
× 100]), and the square root of the mean of squared differences of adjacent 
RR intervals (RMSSD). The SDNN represents overall HRV, whereas RMSSD 
represents parasympathetic influence over HR. The analysis of HRV also calcu-
lated frequency domain parameters, particularly low frequency (LF) and high 
frequency (HF), and the ratio of these two frequency domains (LF/HF). LF is 
generally believed to represent a mixture of sympathetic and parasympathetic 
tone, whereas HF indicates cardiac parasympathetic (vagal) tone, and LF/HF 
serves as an index of sympathovagal balance.
Statistics. The statistical analyses of the Buxco, ECG, and HRV data 
in this study used SAS version 9.2 software (SAS Institute Inc., Cary, NC). 
We used PROC MIXED of SAS because it offers greater flexibility for the 
modeling of repeated measures data than PROC GLM. It is also suitable 
for analysis of large, unbalanced data with missing data at random. A linear 
mixed model with restricted maximum-likelihood estimation analysis, least 
squares means, and repeated measures ANOVA was used to determine which 
TIME × TRT interactions were statistically significant between baseline and 
exposure. Multiple comparison adjustment for the p values and confidence 
limits for the differences between the least squares means was done using 
adjust = Tukey HSD test. All blood gas data were analyzed using GraphPad 
Prism (GraphPad Software, Inc., La Jolla, CA) with a one-way ANOVA 
model examining the main effects of each model. All strain comparisons 
were performed using GraphPad Prism (GraphPad Software, Inc.) with a 
Student t-test. Trend analysis of SDNN data during exposure and HR data 
during hypoxia challenge was performed using GraphPad Prism (GraphPad 
Software, Inc.) with a one-way ANOVA followed by a post hoc test for linear 
trend between mean and column number. A value of p < 0.05 was considered 
statistically significant.
rESuLTS
Effect of Acrolein on HR, BP, and HRV
HRs increased in SH rats during all 3 h of acrolein exposure 
(Fig. 2A). At hour 1, mean heart rates increased from baseline 
levels of 294.4 ± 5.4 beats per minute (bpm) to 313.3 ± 15.3 
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bpm. At hour 2, mean heart rates increased from baseline lev-
els of 269.2 ± 3.9 bpm to 297.7 ± 16.0 bpm. At hour 3, mean 
heart rates increased from baseline levels of 274.1 ± 6.7 bpm 
to 305 ± 16.7 bpm. When each acrolein-exposed rat is com-
pared with itself during air exposure, these changes consti-
tuted a 10.3 ± 4.22% increase from air at hour 1, a 10.8 ± 4.57% 
increase from air at hour 2, and a 14.6 ± 3.17% increase from air 
at hour 3 (p < 0.05; Fig. 2A). HR did not change in WKY rats 
during acrolein exposure.
Before exposures commenced, the baseline BP values for all 
rats were calculated, and it was determined that SH rats had 
an average of 44 mmHg higher baseline mean arterial BP level 
than WKY rats (162.46 ± 3.71 mmHg vs. 118.57 ± 4.26 mmHg, 
respectively), consistent with their hypertensive phenotype. 
Mean arterial BP increased during hour 2 of acrolein exposure 
in SH rats and during hour 3 of acrolein exposure in both SH and 
WKY rats (Fig. 2B). In SH rats, mean arterial BP increased from 
baseline levels of 150.20 ± 2.35 mmHg to 169.65 ± 4.04 mmHg at 
hour 2, constituting a 15.19 ± 2.51% increase from air (p < 0.05; 
Fig. 2B). At hour 3, mean arterial BP increased from baseline 
levels of 154.14 ± 2.07 mmHg to 189.32 ± 4.06 mmHg, consti-
tuting a 23.67 ± 2.79% increase from air in SH rats (p < 0.05; 
Fig.  2B). The increases in mean arterial BP at hour 3 were 
accompanied by 22.86 ± 3.38% and 23.31 ± 3.30% increases in 
systolic and diastolic BP, respectively. In WKY rats, BP signifi-
cantly increased from baseline levels of 120.15 ± 2.74  mmHg 
to 130.24 ± 5.38 mmHg at hour 3, constituting a 14.44 ± 2.55% 
increase from air (p < 0.05; Fig. 2B).
SH rats also had a significant increase in the LF HRV param-
eter during hour 3 of acrolein exposure (Fig. 2C). LF increased 
from baseline levels of 1.55 ± 0.37 to 3.07 ± 0.51 ms2, constitut-
ing a 109.39 ± 29.74% increase from air (p < 0.05; Fig. 2C). In 
addition, SH rats had a nonsignificant decrease in SDNN during 
all hours of acrolein exposure, but there was a significant nega-
tive trend in the data (p = 0.0275; r2 = 0.2076) (Fig. 2D). There 
were no significant changes in RMSSD, HF, and LF/HF in SH 
rats, and there were no significant changes in any HRV param-
eter in WKY rats.
Ventilatory Changes During Acrolein Exposure
SH rats had a significant increase in breathing frequency and 
minute volume in the third hour of acrolein exposure (Figs. 3A 
and B). Breathing frequency increased from baseline levels of 
101.33 ± 8.86 breaths per minute at baseline to 122.95 ± 12.96 
breaths per minute at hour 3, constituting a 34 ± 8.61% increase 
from air (p < 0.05; Fig.  3A). Minute volume increased from 
149.87 ± 11.4 ml at baseline to 181.4 ± 20.85 ml at hour 3 of 
acrolein exposure, constituting an increase of 25 ± 4.27% from 
Fig. 2.  Acrolein exposure causes increases in HR, mean arterial BP, and the LF component of HRV in SH rats. Panels (A), (B), (C), and (D) relate to HR, BP, 
LF, and SDNN values at baseline and all 3 h of acrolein exposure, respectively. Panels (A), (B), (C), and (D) are presented as % change from air. Percent change 
baseline values are compared with the average % change values during each hour of exposure. Means and standard errors are reported. Significant differences 
from baseline percent change values (p < 0.05) are denoted with *. Significant differences (p < 0.05) between SH and WKY strains at each hour are denoted with 
#. There was a significant negative trend in the SDNN data (p = 0.0275; r2 = 0.2076).
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air (p < 0.05; Fig. 3B). There were no significant changes in 
ventilatory parameters during acrolein exposure in WKY rats.
Electrocardiographic Changes and Arrhythmogenesis 
During Acrolein Exposure
There were no significant changes in PR interval, QRS inter-
val or area, and ST- or T-wave area in SH and WKY rats exposed 
to acrolein (Supplementary table I). WKY rats did have a sig-
nificant increase in the ST segment, but this change occurred 
during exposure to air and is not related to acrolein exposure 
(Supplementary table I). There were no significant changes in 
ECG, HRV, or arrhythmia after either hypoxia challenge. There 
were no significant changes in the frequency of spontaneous 
arrhythmia during or after acrolein exposure.
Validation of the Hypoxia Stress Test
All data for hypoxia validation are presented in Table I. A sep-
arate cohort of SH and WKY rats implanted with femoral artery 
catheters underwent the hypoxia stress test, and blood samples 
were analyzed before exposure to the 10% chamber O
2
 atmos-
phere, during exposure to the 10% chamber O
2
 atmosphere, 
and after the return to normal 20% chamber O
2
 concentration. 
Exposure to 10% chamber O
2





, and arterial blood O
2
 saturation in both strains of 
rats. In SH rats, pO
2
 levels decreased from 98.6 ± 2.42 mmHg 
at baseline to 50.20 ± 1.71  mmHg during exposure to 10% 
chamber O
2
 and increased again to 94.60 ± 4.53  mmHg after 
O
2
 levels were returned to 20% (p < 0.05; Table I). In WKY 
rats, pO
2
 levels decreased from 99.80 ± 5.16 mmHg at baseline 
to 54.80 ± 2.60  mmHg during exposure to 10% chamber O
2
 
and increased again to 95.40 ± 1.89 mmHg after O
2
 levels were 
returned to 20% (p < 0.05; Table I).
In SH rats, pCO
2
 levels decreased from 37.00 ± 1.00 mmHg 
at baseline to 31.00 ± 0.84  mmHg during exposure to 10% 
chamber O
2
 and increased again to 38.20 ± 1.80 mmHg after O
2
 
levels were returned to 20% (p < 0.05; Table I). In WKY rats, 
pCO
2
 levels decreased from 41.40 ± 2.86 mmHg at baseline to 
28.60 ± 1.25 mmHg during exposure to 10% chamber O
2
 and 
increased again to 41.80 ± 1.80 mmHg after oxygen levels were 
returned to 20% (p < 0.05; Table I).
In SH rats, SaO
2
 levels decreased from 93.60 ± 0.51% at base-
line to 79.40 ± 0.68% during exposure to 10% chamber O
2
 and 
increased again to 94.20 ± 0.37% after O
2
 levels were returned 
to 20% (p < 0.05; Table  I). In WKY rats, O
2
 saturation levels 
Fig. 3.  Acrolein exposure causes significant increases in breathing frequency and minute volume in SH rats. Panels (A) and (B) relate to breathing frequency 
and minute volume, respectively, measured at baseline, 1, 2, and 3 h during acrolein exposure. All values are presented as % change from air. Percent change base-
line values are compared with the average % change values during each hour of exposure. Significant differences from baseline percent change values (p < 0.05) 
are denoted with *. Significant differences (p < 0.05) between SH and WKY strains at each hour are denoted with #.
TAbLE 1







 (%) pH K+ (mmol/l)
SH rat Baseline 98.60 ± 2.42 37.00 ± 1.00 93.60 ± 0.51 7.31 ± 0.033 7.66 ± 1.10
10% chamber O
2
50.20 ± 1.71* 31.00 ± 0.84* 79.40 ± 0.68* 7.47 ± 0.044 7.36 ± 0.81
20% chamber O
2
94.60 ± 4.53 38.20 ± 1.80 94.20 ± 0.37 7.39 ± 0.048 6.70 ± 0.72
WKY rat Baseline 99.80 ± 5.16 41.40 ± 2.86 94.60 ± 0.68 7.41 ± 0.045 5.70 ± 0.49
10% chamber O
2
54.80 ± 2.60* 28.60 ± 1.25* 82.40 ± 0.68* 7.43 ± 0.070 5.80 ± 0.87
20% chamber O
2
95.40 ± 1.89 41.80 ± 1.80 93.40 ± 0.40 7.40 ± 0.023 5.76 ± 0.69




, and blood SaO
2
 in arterial blood in SH and WKY rats. pH and K+ concentrations are also 
reported. Means and standard errors are reported.
Significant differences (p < 0.05) are denoted with *.
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decreased from 94.60 ± 0.68% at baseline to 82.40 ± 0.68% during 
exposure to 10% chamber O
2
 and increased again to 93.40 ± 0.40% 
after O
2
 levels were returned to 20% (p < 0.05; Table I).
BP and HR Changes During Hypoxia Stress Test
Hypoxia stress test was initially performed 24 h after a 3-h 
exposure to air. The 10% chamber O
2
 concentration caused 
similar increases in HR in both the SH and WKY rats during 
the hypoxia period but did not affect systolic BP in either strain 
(data not shown).
Hypoxia stress test after acrolein exposure caused a signifi-
cant increase in diastolic BP during exposure to 10% chamber 
O
2
 in SH rats (p < 0.05; Fig. 4A). Diastolic BP increased from 
124.99 ± 5.16 mmHg at baseline to 135.99 ± 2.51 mmHg dur-
ing exposure to 10% chamber O
2
, constituting a 12.11 ± 2.23% 
increase from air (p < 0.05; Fig. 4A). The hypoxia stress test 
caused a nonsignificant decrease in HR during the descend 
period, the time during which chamber O
2
 saturation decreases 
from 20 to 10%, in the SH rat and a nonsignificant increase in 
HR during exposure to 10% chamber O
2
 in WKY rats (Fig. 4B). 
In addition, SH rats displayed a higher baseline BP than WKY 
rats during the entire hypoxia stress test.
Respiratory Changes During Hypoxia Stress Test
Hypoxia stress test following air exposure increased breath-
ing frequency and minute volume in SH and WKY rats during 
the descent and hypoxia period of the stress test and decreased 
expiratory time in SH and WKY rats during the descend period 
(data not shown). The magnitudes of these changes were simi-
lar between the two strains.
WKY rats, but not SH rats, showed significant increases 
in minute volume and expiratory time during hypoxia 
stress test performed after acrolein exposure. Minute 
volume increased from baseline levels of 125.00 ± 11.74 
to 187.36 ± 9.49 ml, constituting a 57.93 ± 23.8% increase 
from air (p < 0.05; Fig. 5A). Expiratory time increased from 
baseline levels of 0.30 ± 0.02 to 0.72 ± 0.03 s, constituting a 
130.02 ± 31.60% change from air during the ascend period 
(p < 0.05; Fig. 5B).
Arrhythmogenesis, Electrocardiographic, and HRV Changes 
During Hypoxia Stress Test
There were no significant changes in frequency of sponta-
neous arrhythmia, electrocardiographic, or HRV parameters 
during the hypoxia stress test after acrolein exposure in SH or 
WKY rats (Supplementary tables II and III, respectively).
DiScuSSioN
This study demonstrates that acrolein exposure alone 
increases HR, mean arterial BP, breathing frequency, and min-
ute volume in the hypertensive SH rat, with limited effects in the 
normotensive WKY rat. The cardiovascular responses in the SH 
rat during acrolein exposure were coupled with increases in the 
HRV parameter LF indicative of altered autonomic tone. The 
hypoxia stress test performed after acrolein exposure revealed 
additional strain-dependent cardiopulmonary responses includ-
ing increased diastolic BP only in the SH rat and increased min-
ute volume and expiratory time only in WKY rats.
Fig. 4.  Hypoxia stress test after acrolein exposure causes significant increases in diastolic BP in SH rats. Panels (A) and (B) refer to diastolic BP and HR, 
respectively, measured at baseline, the descend period, 10% FIO
2
, the ascend period, and the return to 20% FIO
2
. All values are presented as % change from 
hypoxia challenge after air exposure. Percent change baseline values are compared with the average % change values during the different segments of the hypoxia 
challenge. Means and standard errors are reported. Significant differences from baseline percent change values (p < 0.05) are denoted with *. Significant differ-
ences (p < 0.05) between SH and WKY strains at each hour are denoted with #.
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The increases in HR and BP during acrolein exposure in 
the hypertensive rat may be related to altered autonomic tone 
during exposure. Chronic exposure to acrolein in mice has 
been linked to left ventricular dilation (Ismahil et  al., 2011) 
and progression of atherosclerosis (Srivastava et  al., 2011), 
whereas acute exposure to 3 ppm acrolein in this study 
caused significant increases in HR in SH rats during all 3 h of 
exposure. This was accompanied by increases in BP and the LF 
component of HRV and, although not statistically significant, a 
decrease in SDNN. Although the implications of these changes 
in rats are unclear, similar changes in humans are consistent 
with elevated sympathetic tone and an increased risk of heart 
disease (Pope et al., 2001). In addition, iv injection of acrolein 
causes significant increases in BP that are reversed with 
guanethidine, a sympatholytic drug (Green and Egle, 1983). 
Despite these findings, there were no significant changes in LF/
HF, a measure of sympathetic and parasympathetic balance. 
Furthermore, LF alone may not be a reliable indicator of 
sympathetic tone and may instead reflect an interaction of 
the sympathetic and parasympathetic nervous systems (Houle 
and Billman, 1999). Thus, further work is required to confirm 
linkages with altered autonomic tone. Although WKY rats 
had a significant increase in BP in the third hour of acrolein 
exposure, this response was not accompanied by increases in 
HR or any significant changes in HRV.
The hypoxia stress test revealed exaggerated cardiovascu-
lar sensitivity, characterized by increased diastolic BP, only 
in acrolein-exposed SH rats. This response may be due to 
increased vascular resistance as in vivo acrolein exposure in 
SH rats has been shown to increase ex vivo aortic reactivity 
(Conklin et al., 2006). Hypoxia has been shown to heighten 
sympathetic activation in healthy men during periods of 
submaximal exercise (Al Haddad et  al., 2012). In addition, 
chronic intermittent hypoxia has been shown to increase 
arterial BP and impair vasodilation through increased levels 
of angiotensin II (Marcus et al., 2012). Carotid body–medi-
ated sensation of low blood SaO
2
 levels triggers reflex car-
diovascular responses including tachycardia, hypertension, 
and increased cardiac output (Downing et  al., 1962). SH 
rats have larger carotid bodies (Habeck et  al., 1985) and 
are more sensitive to the effects of hypoxia as evidenced by 
increased carotid sinus nerve activity and intracellular Ca2+ 
changes (Weil et  al., 1998). Thus, differential carotid body 
sensitivity may in part underlie the differences in responses 
to acrolein and hypoxia in normotensive and hypertensive 
rats. Recent work by Wang et  al. (2012) demonstrated that 
particulate matter exposure–induced cardiac arrhythmias in 
mice with heart failure were in part due to dysregulation of 
carotid body sensitivity. Further research is required to exam-
ine the impact of carotid body sensitivity and the potential 
effects of air pollutant exposure on carotid body–mediated 
cardiovascular responses. Although the ventilatory responses 
to hypoxia after the mock air exposure were similar in SH and 
WKY rats, only WKY rats exposed to acrolein had signifi-
cant increases in minute volume and expiratory time during 
the hypoxia stress test. It is unclear exactly why these ventila-
tory responses occurred only in WKY rats and not in SH rats, 
but it may relate to the increased respiratory sensitivity to air 
pollutant inhalation in the SH rat compared with the WKY 
rat. Previous studies (Farraj et al., 2011) have shown that SH 
rats respond with greater airway inflammation and injury after 
air pollution exposure than WKY rats, and underlying sus-
ceptibility in the SH rat may result in the nerve fibers being 
overloaded and unable to illicit a normal response to acrolein. 
Fig. 5.  Hypoxia stress test after acrolein exposure causes significant increases in minute volume and expiratory time in WKY rats. Panels (A) and (B) relate 
to minute volume and expiratory time, respectively, measured at baseline, the descend period, 10% FIO
2
, the ascend period, and the return to 20% FIO
2
. All values 
are presented as % change from hypoxia challenge after air exposure. Percent change baseline values are compared with the average % change values during the 
different segments of the hypoxia challenge. Means and standard errors are reported. Significant differences from baseline percent change values (p < 0.05) are 
denoted with *. Significant differences (p < 0.05) between SH and WKY strains at each hour are denoted with #.
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An acrolein-induced airway lesion in the SH rat may have pre-
cluded a normal ventilatory response to hypoxia during the 
hypoxia stress test (Leikauf et al., 1989).
These findings demonstrate that the hypoxia stress test is 
a novel approach to reveal latent responses to air pollutants. 
Researchers are becoming increasingly interested in latent 
responses to air pollution exposure, and stress tests provide a 
useful model to study latent effects that would be missed in an 
acute exposure setting. Traditionally, epidemiological studies 
have estimated morbidity and mortality within 24 h of air 
pollution events. Although this time frame reveals significant 
increases in cardiovascular events after air pollution exposure, 
it may miss equally severe delayed responses that can occur 
up to 3  days (Faustini et  al., 2011) and even 2 weeks after 
exposure (Goodman et  al., 2004). Several stress tests have 
been used to determine enhanced sensitivity to air pollutants 
including exercise stress test in humans (Gold et al., 2005), 
dobutamine stress test in rats (Hazari et  al., 2012), and 
isoproterenol cardiac stress test in rats (André et al., 2011). 
Intermittent hypoxia has been used to model nocturnal 
desaturation in sleep apnea patients (Norton et  al., 2011). 
We designed a new hypoxia stress test with one prolonged 
(10 min) acute session of hypoxia followed by a return to 
normoxic conditions. The effects of the 10% O
2
 atmosphere 
were validated by measuring blood O
2
 saturation in arterial 







 decreased significantly 
during hypoxia in both strains of rats. In addition, pH was not 
significantly affected by hypoxia challenge, demonstrating 
that the rat completely compensates for the drop in pCO
2,
 
suggesting that the effects are not due to metabolic acidosis. 
Normal pO
2
 levels in humans range from 80 to 100 mmHg, 
and a drop in partial pressure below 60 mmHg is required for 
hypoxemia. Normal pCO
2
 levels in the humans range from 
35–45 mmHg, and the hypoxia stress test reduced pCO
2
 levels 
well below this level. Although the stress test was used in this 
context to examine susceptibility after air pollution exposure, 
the data suggest that it can easily be applied to different 
models to examine overall cardiovascular sensitivity.
The exaggerated effects of acrolein in the SH rats in this 
study are consistent with our previous studies with other air 
pollutants indicating enhanced sensitivity in this strain (Farraj 
et al., 2011; Lamb et al., 2012). In this study, SH rats had an 
average of 44  mmHg higher BP than WKY rats. It has long 
been known that hypertension increases the risk of cardiovas-
cular disease and stroke (Brook et  al., 2010). In addition to 
higher baseline BP, SH rats have increased arterial wall thick-
ness (Mulvany and Halpern, 1977) and undergo left ventricular 
remodeling characterized by hypertrophy, fibrosis, and changes 
in membrane channels, cellular energetics, and ion regulation 
that combine to heighten myocardial sensitivity (Bernardo 
et  al., 2010). SH rats were not only more susceptible to HR 
and BP increases during acrolein exposure, they also had sig-
nificant increases in breathing frequency and minute volume 
in the third hour of exposure. Previous studies have found that 
acrolein, like other pulmonary irritants, causes decreases in res-
piratory rate (Hazari et al., 2008). It is unclear why SH rats had 
increased breathing frequency at hour 3 of acrolein exposure, 
but it is possible that these responses were secondary to the sig-
nificant increases in HR and BP that were initiated during hours 
1 and 2 of acrolein exposure. Minute volume tends to increase 
with exercise or stress, and it has been shown to increase with 
acrolein exposures (Linhart et al., 1996). Taken together, the 
results demonstrate that the SH rat has increased susceptibility 
to the adverse effects of acrolein exposure, including cardiovas-
cular effects that appear directly and immediately and priming 
effects through homeostatic control pathways perhaps involv-
ing autonomic reflexes that set the stage for latent responsive-
ness to various stimuli.
The present findings demonstrate that acrolein-induced car-
diovascular responses may result from modulation of auto-
nomic tone, specifically increased sympathetic input to the 
heart. These findings also highlight the utility of the hypoxia 
stress test as a tool to unmask the potential for latent effects 
of air pollution via less appreciated mechanisms that medi-
ate cardiovascular dysfunction associated with exposure to air 
pollution. To further examine the utility of this hypoxia stress 
test, we will assess the effects of exposure to other gaseous and 
particulate air pollutants (e.g., ozone and diesel exhaust) in 
future studies. Finally, the results further show that pre-existing 
cardiovascular disease confers exaggerated sensitivity to the 
effects of a model irritant, acrolein, that are consistent with 
the temporal relationship between exposure and clinical out-
comes observed in epidemiological studies showing “delayed 
or latent” outcomes of air pollutant exposures.
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